Delisted from NASDAQ in July 2023
NH - NantHealth, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Culver City,
United States
Type: Equity
NH price evolution
NH
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $14.15 | $1.76 | $0.64 | $5.71 |
| Short term investments | ||||
| Net receivables | $8.14 | $7.36 | $6.71 | $6.57 |
| Inventory | ||||
| Total current assets | $24.71 | $12.59 | $12.15 | $14.86 |
| Long term investments | ||||
| Property, plant & equipment | $15.75 | $16.67 | $16.36 | $17.1 |
| Goodwill & intangible assets | $127.35 | $128.44 | $130.68 | $132.91 |
| Total noncurrent assets | $144.79 | $146.97 | $148.76 | $152.02 |
| Total investments | ||||
| Total assets | $169.5 | $159.55 | $160.91 | $166.89 |
| Current liabilities | ||||
| Accounts payable | $13.21 | $12.34 | $11.04 | $7.76 |
| Deferred revenue | $4.14 | $3.77 | $4.06 | $4.08 |
| Short long term debt | $0.56 | $1.11 | ||
| Total current liabilities | $38.39 | $35.63 | $33.59 | $23.59 |
| Long term debt | $285.29 | $264.74 | $254.2 | $254.75 |
| Total noncurrent liabilities | $367.76 | $349.31 | $328.49 | $331.39 |
| Total debt | $285.29 | $265.3 | $255.31 | $254.75 |
| Total liabilities | $406.14 | $384.94 | $362.07 | $354.99 |
| Shareholders' equity | ||||
| Retained earnings | -$1132.92 | -$1120.68 | -$1095.02 | -$1081.36 |
| Other shareholder equity | -$0.55 | -$0.63 | -$0.91 | -$0.59 |
| Total shareholder equity | -$236.65 | -$225.39 | -$201.16 | -$188.1 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1.76 | $29.08 | $22.79 | $5.24 |
| Short term investments | ||||
| Net receivables | $7.36 | $7.33 | $5.13 | $12.85 |
| Inventory | $0.8 | |||
| Total current assets | $12.59 | $39.41 | $30.59 | $37.91 |
| Long term investments | $31.7 | |||
| Property, plant & equipment | $16.67 | $18.41 | $20.64 | $26.17 |
| Goodwill & intangible assets | $128.44 | $137.37 | $146.3 | $167.78 |
| Total noncurrent assets | $146.97 | $158.42 | $169.69 | $228.57 |
| Total investments | $31.7 | |||
| Total assets | $159.55 | $197.83 | $200.29 | $266.49 |
| Current liabilities | ||||
| Accounts payable | $12.34 | $8.37 | $9.36 | $8.07 |
| Deferred revenue | $3.77 | $4.46 | $1.56 | $18.03 |
| Short long term debt | $0.56 | $0.78 | $100.26 | $0.24 |
| Total current liabilities | $35.63 | $27.95 | $124.76 | $57.5 |
| Long term debt | $264.74 | $255.78 | $120.84 | $217.19 |
| Total noncurrent liabilities | $349.31 | $331.88 | $186.93 | $266.12 |
| Total debt | $265.3 | $256.57 | $221.09 | $217.43 |
| Total liabilities | $384.94 | $359.82 | $311.69 | $323.62 |
| Shareholders' equity | ||||
| Retained earnings | -$1120.68 | -$1052.9 | -$1003.21 | -$946.88 |
| Other shareholder equity | -$0.63 | -$0.21 | -$0.17 | -$0.22 |
| Total shareholder equity | -$225.39 | -$161.99 | -$111.78 | -$57.14 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $17.05 | $17.5 | $16.63 | $16.5 |
| Cost of revenue | $6.42 | $7.38 | $6.93 | $7.35 |
| Gross Profit | $10.63 | $10.11 | $9.71 | $9.15 |
| Operating activities | ||||
| Research & development | $5.16 | $5.17 | $6.3 | $5.86 |
| Selling, general & administrative | $16.7 | $16.92 | $16.58 | $14.02 |
| Total operating expenses | $22.85 | $23.08 | $23.86 | $20.86 |
| Operating income | -$12.23 | -$12.97 | -$14.16 | -$11.71 |
| Income from continuing operations | ||||
| EBIT | -$8.01 | -$22.27 | -$10.16 | -$9.07 |
| Income tax expense | $0.07 | -$0.3 | -$0.01 | -$0.03 |
| Interest expense | $4.15 | $3.69 | $3.51 | $3.47 |
| Net income | ||||
| Net income | -$12.24 | -$25.66 | -$13.66 | -$12.51 |
| Income (for common shares) | -$12.24 | -$25.66 | -$13.66 | -$12.51 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $67 | $62.65 | $73.17 | $95.96 |
| Cost of revenue | $28.84 | $27.81 | $29.23 | $38.42 |
| Gross Profit | $38.16 | $34.84 | $43.95 | $57.54 |
| Operating activities | ||||
| Research & development | $23.05 | $19.71 | $17.27 | $19.07 |
| Selling, general & administrative | $62.5 | $52.09 | $48.53 | $61.04 |
| Total operating expenses | $89.49 | $75.74 | $70.21 | $88.31 |
| Operating income | -$51.33 | -$40.9 | -$26.27 | -$30.77 |
| Income from continuing operations | ||||
| EBIT | -$53.98 | -$43.68 | -$36.68 | -$44.83 |
| Income tax expense | -$0.32 | $0.1 | $0.45 | -$0.11 |
| Interest expense | $14.12 | $14.48 | $19.2 | $18.04 |
| Net income | ||||
| Net income | -$67.78 | -$58.26 | -$56.33 | -$62.76 |
| Income (for common shares) | -$67.78 | -$58.26 | -$56.33 | -$62.76 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Net income | -$12.24 | -$25.66 | -$13.66 | -$12.51 |
| Operating activities | ||||
| Depreciation | $2.95 | $4.08 | $4.01 | $3.88 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.88 | $1.12 | $0.89 | $1.26 |
| Total cash flows from operations | -$6.57 | -$7.05 | -$5.02 | -$9.14 |
| Investing activities | ||||
| Capital expenditures | -$1.26 | -$2.31 | -$1.29 | -$1.66 |
| Investments | ||||
| Total cash flows from investing | -$1.26 | -$2.31 | -$1.29 | -$1.66 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | $21.37 | $10.45 | $1.11 | |
| Total cash flows from financing | $20.6 | $10.45 | $1.11 | |
| Effect of exchange rate | -$0.38 | $0.04 | $0.13 | -$0.03 |
| Change in cash and equivalents | $12.39 | $1.12 | -$5.08 | -$10.84 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$67.78 | -$58.26 | -$56.33 | -$62.76 |
| Operating activities | ||||
| Depreciation | $15.99 | $15.72 | $16.77 | $22.36 |
| Business acquisitions & disposals | $40.93 | $0.3 | ||
| Stock-based compensation | $4.67 | $3.89 | $2.65 | $2.79 |
| Total cash flows from operations | -$32.26 | -$27.69 | -$16.85 | -$8.77 |
| Investing activities | ||||
| Capital expenditures | -$6.47 | -$5.08 | -$5.67 | -$4.59 |
| Investments | -$0.56 | |||
| Total cash flows from investing | -$6.47 | -$5.64 | $35.25 | -$4.29 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.02 | $0.29 | $0.17 | |
| Net borrowings | $10.78 | $40.56 | $0.01 | $0.24 |
| Total cash flows from financing | $10.8 | $40.58 | -$0.56 | -$0.03 |
| Effect of exchange rate | $0.09 | -$0.01 | -$0.06 | $0.03 |
| Change in cash and equivalents | -$27.84 | $7.24 | $17.78 | -$13.06 |
News
Fundamentals
| Market cap | $3.25M |
|---|---|
| Enterprise value | $274.39M |
| Shares outstanding | 7.70M |
| Revenue | $67.68M |
|---|---|
| EBITDA | -$34.58M |
| EBIT | -$49.51M |
| Net Income | -$64.07M |
| Revenue Q/Q | 4.13% |
| Revenue Y/Y | 7.68% |
| P/E ratio | -0.05 |
|---|---|
| EV/Sales | 4.05 |
| EV/EBITDA | -7.93 |
| EV/EBIT | -5.54 |
| P/S ratio | 0.05 |
| P/B ratio | -0.01 |
| Book/Share | -30.65 |
| Cash/Share | 1.84 |
| EPS | -$8.32 |
|---|---|
| ROA | -39.02% |
| ROE | 30.10% |
| Debt/Equity | -1.71 |
|---|---|
| Net debt/EBITDA | -11.33 |
| Current ratio | 0.64 |
| Quick ratio | 0.64 |